Insider Trading Summary (Last 30 Days)
See how company executives and directors have been buying or selling shares over the past 30 days. Insider trading activity can help investors better understand company leadership's actions.
1
1
$0.00
$5.28M
Insider Trading History (Last 12 Months)
Browse insider buying and selling activity reported to the SEC over the past year, including who traded, when they traded, and the value of each transaction.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Nov 17, 2026 PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG |
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG
EVP & Chief Admin Officer
|
Sell |
20,000 | $263.89 | 20,000 $263.89 $5,277,720 |
Sep 08, 2026 Bodenhoff Mads |
Bodenhoff Mads
SVP & PAO
|
Sell |
3,000 | $270.19 | 3,000 $270.19 $810,570 |
Aug 14, 2026 BIENAIME JEAN JACQUES |
BIENAIME JEAN JACQUES
|
Buy |
1,100 | $245.85 | 1,100 $245.85 $270,435 |
Aug 14, 2026 BIENAIME JEAN JACQUES |
BIENAIME JEAN JACQUES
|
Buy |
900 | $246.91 | 900 $246.91 $222,219 |
Jun 02, 2026 SMITH SCOTT THOMAS |
SMITH SCOTT THOMAS
EVP & CHIEF FINANCIAL OFFICER
|
Buy |
100 | $219.00 | 100 $219.00 $21,900 |
May 29, 2026 BIENAIME JEAN JACQUES |
BIENAIME JEAN JACQUES
|
Buy |
200 | $223.76 | 200 $223.76 $44,752 |
May 29, 2026 BIENAIME JEAN JACQUES |
BIENAIME JEAN JACQUES
|
Buy |
200 | $222.30 | 200 $222.30 $44,460 |
May 29, 2026 BIENAIME JEAN JACQUES |
BIENAIME JEAN JACQUES
|
Buy |
100 | $223.50 | 100 $223.50 $22,350 |
May 29, 2026 SMITH SCOTT THOMAS |
SMITH SCOTT THOMAS
EVP & CHIEF FINANCIAL OFFICER
|
Buy |
250 | $223.32 | 250 $223.32 $55,830 |
May 26, 2026 BIENAIME JEAN JACQUES |
BIENAIME JEAN JACQUES
|
Buy |
200 | $236.24 | 200 $236.24 $47,247 |
May 26, 2026 BIENAIME JEAN JACQUES |
BIENAIME JEAN JACQUES
|
Buy |
200 | $239.37 | 200 $239.37 $47,874 |
May 11, 2026 JENSEN FLEMMING STEEN |
JENSEN FLEMMING STEEN
See Remarks
|
Sell |
19,460 | $238.49 | 19,460 $238.49 $4,641,021 |
Historical Insider Trading
View older insider trading records reported to the SEC to research long-term buying and selling trends.
No Historical Insider Transactions found for Ascendis Pharma A/S